Skip to Main Content
February 10, 2023
Health Law Weekly

Featured Articles

DOJ Eliminates Health Care “Antitrust Safety Zones”

  • Vic Domen, Norton Rose Fulbright US LLP
  • Gerald Stein, Norton Rose Fulbright US LLP
  • Carsten Reichel, Norton Rose Fulbright US LLP

Leadership Update: New Decision Extends Caremark Duties to Corporate Officers

  • Michael W. Peregrine, McDermott Will & Emery

Top Ten 2023: Data Privacy Requirements

Current Topics

Fraud and Compliance

Behavioral Health Provider Pays $384K to Settle Overbilling Allegations

Cardiac Monitoring Company Pays $673,000 to Resolve False Billing Allegations

Centene Settles California’s Medi-Cal Fraud Allegations for $215 Million

Device Maker Agrees to Pay $500,000 to Resolve Medicaid Fraud Allegations

DME Company Owners Convicted in Medicaid Fraud Scheme

DOJ Reports False Claims Act Recoveries of $2.2 Billion in FY 2022

Health Care Provider to Pay $26 Million to Resolve Fraud Allegations

LabCorp to Pay $19 Million to Resolve Whistleblowers’ Action Alleging Kickback Scheme

Physician Gets 30 Months in Prison for Kickback Scheme

Twenty-Three Charged in $61.5 Million Medicare Fraud Schemes

U.S. Court in New Mexico Allows Whistleblower’s Medicaid Overpayments Claim Against United Behavioral Health

Government Reimbursement

CMS Offers First Look at Medicare Prescription Drug Inflation Rebate Program

Hospital Price Transparency Rule Compliance Continues to Fall Short, Group Reports

OIG Flags Implementation Challenges for Medicare Inflation Rebates

Online Pharmacy to Pay $15 Million for Alleged Medicaid Fraud Scheme in California

Health Care Finance and Transactions

CVS Moves to Expand Health Care Delivery with $10.6 Billion Oak Street Health Acquisition

Health Insurance

U.S. Court in Texas Nixes Revised No Surprises Act Dispute Resolution Rule

Health Policy and Administration

Biden Emphasizes Post-COVID Health Care Priorities in State of the Union

HHS Issues Letter to State Governors on End of COVID-19 Public Health Emergency

Texas Lawsuit Takes Aim at Administration's Pharmacy Guidance on Abortion Medication

Life Sciences

U.S. Court in DC Tosses Challenge to FDA Drug Importation Rule
Current Issue
Health Law Weekly Issue - February 10, 2023